Gaithersburg’s Novavax says it will have an updated Covid-19 vaccine ready after an FDA committee voted unanimously on the ...
Novavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the best-performing companies in New York.
Every investor aspires to see the stocks in their portfolio deliver substantial returns. Though trading is a game of probabilities, with both wins and losses ...
In the stock market, a back-from-the-dead story is equally appealing. Stocks that have been left for dead, or at least seen ...
The top-three investor in Novavax ... malaria vaccine – which uses its Matrix-M adjuvant – had been shipped by partner Serum Institute of India to Africa. The deal with Sanofi includes ...
(Reuters) -Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors ...
after the COVID-19 vaccine maker struck a licensing deal with Sanofi (SASY.PA) , opens new tab. Under a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70 ...
announced a landmark deal with Sanofi where the global pharmaceutical company agreed to co-commercialize Novavax’s Covid-19 vaccine and develop other shots. That agreement, which could be worth ...
after the COVID-19 vaccine maker struck a licensing deal with Sanofi (NASDAQ:SNY). Under a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70 million at a lofty ...